323 related articles for article (PubMed ID: 2559218)
1. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice.
Pinto M; Zehavi-Willner T
Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218
[TBL] [Abstract][Full Text] [Related]
2. The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response.
Rumbaugh KP; Colmer JA; Griswold JA; Hamood AN
Cytokine; 2001 Nov; 16(4):160-8. PubMed ID: 11792126
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
4. Gr-1(+)CD11b(+) cells as an accelerator of sepsis stemming from Pseudomonas aeruginosa wound infection in thermally injured mice.
Kobayashi M; Yoshida T; Takeuchi D; Jones VC; Shigematsu K; Herndon DN; Suzuki F
J Leukoc Biol; 2008 Jun; 83(6):1354-62. PubMed ID: 18372338
[TBL] [Abstract][Full Text] [Related]
5. Role of natural killer dendritic cells in host resistance against Pseudomonas aeruginosa infection after thermal injury in mice.
Kawasaki T; Kobayashi M; Herndon DN; Suzuki F
Shock; 2010 Jul; 34(1):83-9. PubMed ID: 20016409
[TBL] [Abstract][Full Text] [Related]
6. Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
Barnea Y; Carmeli Y; Neville LF; Kahel-Reifer H; Eren R; Dagan S; Navon-Venezia S
Burns; 2009 May; 35(3):390-6. PubMed ID: 18951715
[TBL] [Abstract][Full Text] [Related]
7. Protamine sulfate reduces the susceptibility of thermally injured mice to Pseudomonas aeruginosa infection.
Haynes A; Rumbaugh KP; Park PW; Hamood AN; Griswold JA
J Surg Res; 2005 Jan; 123(1):109-17. PubMed ID: 15652958
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
Pallua N; von Heimburg D
Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
[TBL] [Abstract][Full Text] [Related]
9. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
[TBL] [Abstract][Full Text] [Related]
10. Role of specific delayed-type hypersensitivity in Pseudomonas aeruginosa-infected mice.
Colizzi V; Garzelli C; Campa M; Toca L; Falcone G
Immunology; 1982 Oct; 47(2):337-44. PubMed ID: 6811422
[TBL] [Abstract][Full Text] [Related]
11. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
13. The bovine innate immune response during experimentally-induced Pseudomonas aeruginosa mastitis.
Bannerman DD; Chockalingam A; Paape MJ; Hope JC
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):201-15. PubMed ID: 15970335
[TBL] [Abstract][Full Text] [Related]
14. Experimental studies on bacterial product cantastim derived from Pseudomonas aeruginosa. VI. Protection in tolerant mice.
Caraş I; Sălăgeanu A
Roum Arch Microbiol Immunol; 2004; 63(1-2):47-62. PubMed ID: 16295320
[TBL] [Abstract][Full Text] [Related]
15. Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
Yoshida T; Yoshida S; Kobayashi M; Herndon DN; Suzuki F
J Leukoc Biol; 2010 Jan; 87(1):35-41. PubMed ID: 19843573
[TBL] [Abstract][Full Text] [Related]
16. Burn injury and pulmonary sepsis: development of a clinically relevant model.
Davis KA; Santaniello JM; He LK; Muthu K; Sen S; Jones SB; Gamelli RL; Shankar R
J Trauma; 2004 Feb; 56(2):272-8. PubMed ID: 14960967
[TBL] [Abstract][Full Text] [Related]
17. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
Neely AN; Holder IA; Wiener-Kronish JP; Sawa T
Burns; 2005 Mar; 31(2):153-8. PubMed ID: 15683685
[TBL] [Abstract][Full Text] [Related]
18. Insights into the role of gammadelta T lymphocytes in the immunopathogenic response to thermal injury.
Schwacha MG; Ayala A; Chaudry IH
J Leukoc Biol; 2000 May; 67(5):644-50. PubMed ID: 10811004
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
20. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
Faezi S; Sattari M; Mahdavi M; Roudkenar MH
Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
